Skip to main content
. 2020 Jun 24;25(9):e1346–e1354. doi: 10.1634/theoncologist.2020-0084

Figure 1.

Figure 1

CONSORT diagram.

*, One patient who was randomly assigned to the placebo arm actually received abemaciclib during cycle 1. This patient is counted in the abemaciclib safety population.

Abbreviation: NSAI, nonsteroidal aromatase inhibitor.